Table 1.
Clinical and endoscopic features of 112 patients in the study cohort
| Sex (%) | |
| Male | 59 (52.7) |
| Female | 53 (47.3) |
| Age (median, IQR) | 59.0 (48.2–67.0) |
| Site of neoplasia (%) | |
| Head | 46 (41.1) |
| Body | 28 (25.0) |
| Tail | 32 (28.6) |
| Multifocal/others | 6 (5.3) |
| Type of neoplasia (%) | |
| Nonfunctioning | 85 (75.9) |
| Insulinoma | 21 (18.8) |
| Other functioning | 6 (5.4) |
| CT-scan diameter (median, mm) | 22.0 (15.0–35.0) |
| EUS diameter (median, mm) | 23.5 (IQR 15.0–33.5) |
| Pathology diameter (median, mm) | 22.0 (IQR 14.0–33.75) |
| Main pancreatic duct diameter (mean, mm) | 2.52 (SD±1.87) |
| EUS-contrast pattern (available on 70 patients) (%) | |
| Iper-enhancement | 54 (77.1) |
| Ipo-enhancement | 16 (22.9) |
| EUS-Elastography pattern (available on 93 patients) (%) | |
| Rigid | 57 (61.3) |
| Soft | 11 (9.8) |
| Mixed-pattern | 25 (26.9) |
| Neoplasia pattern (%) | |
| Solid | 83 (74.1) |
| Solid-cystic | 29 (25.9) |
| Delay from EUS to surgery (median, days) | 74.5 (IQR 48.25–135) |
| TNM staging (available on 94 patients) (%)a | |
| 1 | 23 (20.5) |
| 2 | 30 (26.8) |
| 3 | 31 (27.7) |
| 4 | 10 (8.9) |
aBergsland EK, Woltering EA, Rindo G. Neuroendocrine tumors of the pancreas. In: AJCC cancer staging manual, 8th, Amin MB (Ed), AJCC, Chicago 2017. p. 407. CT: Computed tomography; IQR: Interquartile range; SD: Standard deviation; AJCC: American joint committee on cancer